Max Robotics — Global Service Robot Directory + US Certification

About

Daniel Clayburgh is a leading head and neck surgical oncologist whose research has fundamentally advanced the field of transoral robotic surgery (TORS) for oropharyngeal cancer. His work centers on optimizing surgical techniques, improving patient quality of life, and reducing treatment morbidity. Clayburgh’s landmark 2017 study on long-term functional and quality-of-life outcomes after TORS (90 citations) demonstrated that this minimally invasive approach can help patients avoid adjuvant chemotherapy or radiotherapy, preserving swallowing and speech. He has also pioneered strategies to enhance surgical safety, including a randomized controlled trial showing that perioperative corticosteroids significantly improve pain control after TORS (32 citations), and a study establishing prophylactic external carotid artery ligation as an effective method to reduce postoperative bleeding (73 citations). Clayburgh’s research on predictors of extracapsular extension in HPV-associated oropharyngeal cancer (29 citations) and patterns of retropharyngeal node metastasis (24 citations) has refined staging and treatment selection. More recently, he has evaluated next-generation robotic platforms, comparing the da Vinci Single Port system to the Si system (22 citations), and assessed the learning curve for flexible robots (6 citations). His innovative use of intraoperative ultrasonography during TORS (17 citations) further demonstrates his commitment to improving surgical precision. Through these contributions, Clayburgh has established himself as a transformative figure in robotic head and neck surgery.